HNewsWire: The deadline for Pfizer to submit the findings of a research looking at the frequency of heart inflammation after receiving the company's COVID-19 vaccine has passed.
On February 16, 2021, a man gets immunized with the Pfizer-BioNTech COVID-19 vaccine at La Colaborativa in Chelsea, Mass.

Pfizer was required to conduct multiple studies on its vaccine after the FDA approved it in August 2021 because regulators determined that without the studies, there would not be enough data to assess the "known serious risks of myocarditis and pericarditis," or heart inflammation and a related condition.

Regulators were particularly worried about the possibility of subclinical myocarditis, or cardiac inflammation that does not manifest as conventional symptoms.

The FDA directed Pfizer to conduct six trials, each with a different date for completion and presenting final findings to the agency. The first final deadline was set for December 31, 2022.

Pfizer was obliged to provide a report on the trial, which was designed to analyze the incidence of subclinical myocarditis in adults aged 16 to 30 after receiving a third dose of Pfizer's vaccine, or a booster injection.

Pfizer may or may not have reached the deadline. Neither the corporation nor the FDA responded to requests for comment, and neither has released any information regarding the research or its findings since the deadline passed.

The FDA gave Pfizer until June 30, 2022, to finish the trial, followed by another six months to compile and submit the final data.

Pfizer was "conducting additional safety-related post-authorization/post-marketing studies for the PfizerBioNTech COVID-19 Vaccine, including post-marketing requirements to assess known serious serious risks of myocarditis and pericarditis and an unexpected serious risk of subclinical myocarditis," according to a Dec. 8, 2022, memorandum from FDA officials explaining why the FDA authorized Pfizer's bivalent booster without any clinical data.

'Shouldn't Have to' According to Jessica Adams, a former FDA regulatory officer, the study's findings should be made public as soon as possible. "This information should not have to be requested or demanded of us. "We should expect it to be shared quickly by default," Adams commented on Twitter.

The FDA's senior deputy director, Dr. Janet Woodcock, informed Adams in an email that the agency is "not permitted to comment on prospective actions on regulated goods." It is unclear how disclosing research findings links to possible regulatory measures. Others are challenging the FDA's delay in providing details on the research in view of the increasing body of data on post-vaccination adverse effects.

"Why are FDA officials delaying making Pfizer's prospective study data on subclinical myocarditis available to the public when evidence has been published in the medical literature that Pfizer's pre-EUA clinical trials revealed a 36 percent higher risk of serious adverse events in vaccinated participants in comparison to placebo recipients?"
She was referring to a reanalysis of the original study data, which showed that vaccinated individuals were at a greater risk of major adverse outcomes.

"With 79 percent of Americans having received at least one COVID shot and so many vaccinated young adults, particularly physically fit athletes, suffering heart attacks and sudden deaths, public health officials should insist that the company with the largest market share of the COVID vaccine business in the United States be completely transparent about what it knows about the biological mechanisms of heart inflammation induced by the mRNA COVID vaccine, which Pfizer maintains is both safe and effective."

Warning
In June 2021, the FDA updated a warning concerning myocarditis caused by Pfizer and Moderna vaccine to patient and health care provider information sheets. Messenger RNA (mRNA) technology is used in both vaccinations. Prospective vaccine recipients were warned that the risk of myocarditis rose after immunization, especially after the second dosage of the two-dose main series.

If specific symptoms, such as chest discomfort or shortness of breath, arose after immunization, consumers were advised to seek medical attention right once. Authorities in the United States, as well as certain agencies overseas, have subsequently admitted that the vaccinations cause heart inflammation. "The existing data shows a causal connection between mRNA COVID-19 immunization and myocarditis and pericarditis," a senior CDC official stated at a conference in 2022.

Some people have died as a result of post-vaccination inflammation. The Vaccine Adverse Event Reporting System (VAERS), a passive early warning system that informs authorities to suspected vaccine adverse effects, has received 5,163 complaints of post-vaccination myocarditis, pericarditis, or myopericarditis. According to study and authorities, the reports do not indicate a link with a vaccination but are an undercount of the total number of instances.

More than 800,000 such adverse events have been reported to the system as a result of receiving the Pfizer vaccination.

Moderna Research
After clearing Moderna's injection in early 2022, the FDA also mandated the firm to do post-approval research.

Moderna was instructed to conduct six studies, the same number as Pfizer, with the goal of determining the frequency of myocarditis and pericarditis, the long-term effect of myocarditis, and the prevalence of subclinical myocarditis.

Two studies were supposed to be finished by December 31, 2022, but the FDA's deadline for receiving the data isn't until June 30, 2023. Other Moderna and Pfizer study deadlines are months or perhaps years away, with one in 2025 and another in 2028.

Dr. Joseph Fraiman has finally called for an immediate halt to mRNA injections. Doctors who have previously pushed Covid-19 "vaccines" sometimes find themselves in unpleasant situations when they realize the shots are too risky to deliver. The change may be abrupt and shocking, as it was for Dr. Aseem Malhotra, who helped promote the vaccines until his own father died as a result of an adverse response.

Some, such as Dr. Joseph Fraiman, work through the shifting mentality over time. Dr. Fraiman took part in a large, peer-reviewed research last year that found the jabs to be dangerous. He desired additional research, but did not go so far as to demand that it be terminated.

It's long past time to stop these punches from going into just one arm. How much more proof do the powers-that-be need before they stop murdering people? How much more proof do people need to see before they stop allowing the powers-that-be murder them?